Comparing metabolic effects of six different commercial trivalent chromium compounds

Journal of Inorganic Biochemistry

Volumn 102, Issue 11, 2008, Pages 1986-1990

  Preuss, Harry G ^a   Echard, Bobby ^a   Perricone, Nicholas V ^b   Bagchi, Debasis ^c   Yasmin, Taharat ^d   Stohs, Sidney J ^e  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^e Advocare International   (United States)

Author keywords

Blood pressure; Chromium(III) salts; DNA damage; Insulin sensitivity; Lipid peroxidation

Indexed keywords

AMINO ACID CHELATE; CHELAVITE; CHROMIUM DERIVATIVE; CITRIC ACID; INSULIN; LOSARTAN; MALONALDEHYDE; NICOTINIC ACID; PICOLINIC ACID; POLYNICOTINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DRUG EFFECT; DRUG FORMULATION; DRUG MARKETING; HYPERTENSION; INSULIN SENSITIVITY; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHROMIUM; DNA FRAGMENTATION; INSULIN RESISTANCE; LIPID PEROXIDATION; NIACIN; RATS; RATS, INBRED SHR;

EID: 53349146622     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2008.07.012     Document Type: Article

References (27)

1. W. Mertz, The Nutrition Foundation, Washington, DC, vol. 36, 1976, pp. 365-372.
2. Anderson R.A. Clin. Physiol. Biochem. 4 (1985) 31-41
3. Mertz W. Am. Inst. Nutr. 626-633 (1992)
4. Anderson R.A. J. Am. Coll. Nutr. 16 (1997) 404-410
5. Anderson R.A. J. Am. Coll. Nutr. 17 (1998) 548-555
6. Preuss H.G. J. Am. Coll. Nutr. 16 (1997) 397-403
7. Preuss H.G., Bagchi D., and Clouatre D. In: Ghen M.J., Corso N., Joiner-Bey H., Klatz R., and Dratz A. (Eds). The Advanced Guide to Longevity Medicine (2001), Ghen, Landrum, SC 239-250
8. Preuss H.G., and Bagchi D. In: Bronner F. (Ed). Nutritional Aspects and Clinical Management of Chronic Disorders and Diseases (2002), CRC Press, Boca Raton, FL 69-91
9. Crawford V., Scheckenbach R., and Preuss H.G. Diab. Obes. Metabol. 1 (1999) 1-7
10. Grant K.E., Chandler R.M., Castle A.L., and Ivy J.L. Med. Sci. Sports Exerc. 29 (1997) 992-998
11. Preuss H.G., Grojec P.L., Lieberman S., and Anderson R.A. Nephrologie 47 (1997) 325-330
12. Preuss H.G., Wallerstedt D., Talpur D.N., Tutuncuoglu S.O., Echard B., Myers A., Bui M., and Bagchi D. J. Med. 31 (2000) 227-246
13. Preuss H.G., Memon S., Dadgar S.A., and Jiang G. J. Am. Coll. Nutr. 13 (1994) 73-82
14. Liu P.S., and Lin M.K. Toxicology 117 (1997) 45-53
15. Kopilas M.A., Dang L.N., and Anderson H.D. J. Vasc. Res. 44 (2007) 110-118
16. Talpur N., Echard B., Yasmin T., Bagchi D., and Preuss H.G. Mol. Cell. Biochem. 252 (2003) 369-377
17. Wong P.C., Price Jr. W.A., Chiu A.T., Ducia J.V., Carini D.J., Wexler R.R., Johnson A.L., and Timmermans P.B. Am. J. Hypertens. 4 (1991) 288S-298S
18. Mohamadi A., Jarrell S.T., Dadgar-Dehkordi A., Bushehri N., Shi S.J., Andrawis N.S., Myers A., Clouatre D., and Preuss H.G. Heart Dis. 2 (2000) 3-9
19. Sukalski K.A., Pinto K.A., and Berntson J.L. Free Radic. Biol. Med. 14 (1993) 57-65
20. Buege J.A., and Aust S.D. Methods Enzymol. 52 (1978) 302-310
21. Bagchi M., Hassoun E.A., Bagchi D., and Stohs S.J. Free Radic. Biol. Med. 14 (1993) 149-155
22. Bagchi D., Vuchetich P.J., Bagchi M., Tran M.X., Krohn R.L., Ray S.D., and Stohs S.J. Gen. Pharmacol. 30 (1998) 43-50
23. Dunnett C. J. Am. Statis. Assoc. 50 (1955) 1096-1121
24. Preuss H., and Anderson R.A. Clin. Nutr. Metabol. Care 1 (1998) 509-512
25. Jeejeebhoy K.N., Chu R.C., Marliss E.B., Greenberg G.R., and Bruce-Robertson A. Am. J. Clin. Nutr. 30 (1977) 531-538
26. Preuss H.G., Grojec P., Lieberman S., and Anderson R.A. Clin. Nephrol. 47 (1997) 325-330
27. Anderson R.A., Cheng N., Bryden N.A., Polaansky M.M., Cheng N., and Feng J. Diabetes 46 (1997) 1786-1791